Skip to content

Aerobic Walking Exercise for Non-Ambulatory Stroke Survivors

Aerobic Walking Exercise for Non-Ambulatory Stroke Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03479632
Enrollment
40
Registered
2018-03-27
Start date
2018-03-05
Completion date
2020-03-05
Last updated
2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

By doing this study, researchers hope to learn the effects of aerobic exercise on heart, lung, and bone health in people who cannot walk after a stroke.

Interventions

Participants will make 24 visits over an 8 week period, having 3 sessions per week. Each session will last about one hour.

BEHAVIORALStandard physical therapy

Participants will receive standard care they normally would after a stroke.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Independent ambulation before stroke * Be able to understand and follow verbal commands in English * Have physicians' approval for exercise, and be in stable medical condition * Participant's first stroke * Unable to walk independently according to Functional Ambulation Category (FAC) (\<2) after in-patient rehabilitation treatment * Between 6 weeks to 5 years after stroke onset

Exclusion criteria

* Current cardiovascular abnormalities other than stroke such as ischemic cardiovascular event or coronary artery bypass surgery less than 3 months ago * Musculoskeletal disorder which prevents subjects from participating in the exercise * Resting blood pressure more than 200/110 mm Hg * Current or previous pulmonary diseases in the past two years * Osteoporosis and restricted passive movement in the major joints of the lower limbs * Subjects will be excluded if they are unable to speak or understand English and/or unable to travel to the University of Kansas Medical Center (KUMC) Neuromuscular Research Laboratory

Design outcomes

Primary

MeasureTime frame
Resting Heart RateChange from Baseline to Week 8

Secondary

MeasureTime frame
Resting blood pressureChange from Baseline to Week 8
Change in vital capacity (VC)Change from Baseline to Week 8
Change in forced vital capacity (FVC)Change from Baseline to Week 8

Countries

United States

Contacts

Primary ContactAbdulfattah Alqahtani
aalqahtani@kumc.edu832-228-8799

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026